摘要
早产儿视网膜病变(ROP)是指早产儿和低体质量儿发生的视网膜血管异常增殖性疾病。目前ROP的主要治疗方法是激光治疗,虽然可以取得良好的治疗效果,但激光治疗可破坏视网膜组织,导致视野缺损。且手术治疗要求条件高,虽是ROP后期治疗的主要方法,但不易于普及,致ROP不能得到及时治疗。因此,寻找一种安全、有效、易于操作的治疗方法迫在眉睫。而针对ROP发病机制的药物具有很好的疗效,且部分药物已进入临床治疗阶段。
Retinopathy of prematurity（ROP） refers to abnormal proliferative retinal blood vessels in preterm childrenand low birth weight children. Currently,the main treatment of ROP is laser treatment, although it can achieve good thera-peutic effect, it can also destroy retinal tissue, resulting in visual field defect. Surgical treatment requires demanding condi-tions, although is the main method of later treatment of ROP, it is not easy to popularize, that ROP cannot he treated in time.Looking for a safe and effective treatment method easy to operate,is imminent. The drugs for the pathogenesis of ROP has avery good effect, and some drugs have entered the stage of clinical treatment.
出处
《医学综述》
2017年第7期1355-1358,1363,共5页
Medical Recapitulate
关键词
早产儿视网膜病变
药物治疗
血管内皮生长因子
Retinopathy of prematurity
Drug treatment
Vascular endothelial growth factor
